{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:34:05Z","timestamp":1766504045808},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T00:00:00Z","timestamp":1083196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T00:00:00Z","timestamp":1083196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,7,1]]},"DOI":"10.1038\/sj.leu.2403387","type":"journal-article","created":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T10:25:05Z","timestamp":1083234305000},"page":"1200-1206","source":"Crossref","is-referenced-by-count":52,"title":["Topoisomerase II\u03b1 expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome"],"prefix":"10.1038","volume":"18","author":[{"given":"C","family":"Schrader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Meusers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Brittinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Teymoortash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-U","family":"Siebmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Parwaresch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Tiemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,29]]},"reference":[{"issue":"Suppl","key":"BF2403387_CR1","first-page":"29","volume":"31","author":"K Lennert","year":"1975","unstructured":"Lennert K, Stein H, Kaiserling E . Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer 1975; 31 (Suppl): 29\u201343.","journal-title":"Br J Cancer"},{"key":"BF2403387_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/bjc.1980.27","volume":"41","author":"G Tolksdorf","year":"1980","unstructured":"Tolksdorf G, Stein H, Lennert K . Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). Br J Cancer 1980; 41: 168\u2013182.","journal-title":"Br J Cancer"},{"key":"BF2403387_CR3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1126\/science.6610211","volume":"224","author":"Y Tsujimoto","year":"1984","unstructured":"Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM . Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224: 1403\u20131406.","journal-title":"Science"},{"key":"BF2403387_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185\u2013197.","journal-title":"Cancer Cell"},{"key":"BF2403387_CR5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H . Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710\u20131715.","journal-title":"J Immunol"},{"key":"BF2403387_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijc.2910310104","volume":"31","author":"J Gerdes","year":"1983","unstructured":"Gerdes J, Schwab U, Lemke H, Stein H . Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13\u201320.","journal-title":"Int J Cancer"},{"key":"BF2403387_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/hon.2900020406","volume":"2","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H . Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 1984; 2: 365\u2013371.","journal-title":"Hematol Oncol"},{"key":"BF2403387_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","volume":"153","author":"L Quintanilla-Martinez","year":"1998","unstructured":"Quintanilla-Martinez L, Thieblemont C, Fend F, Kumar S, Pinyol M, Campo E et al. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 1998; 153: 175\u2013182.","journal-title":"Am J Pathol"},{"key":"BF2403387_CR9","first-page":"327","volume":"134","author":"BR Schwartz","year":"1989","unstructured":"Schwartz BR, Pinkus G, Bacus S, Toder M, Weinberg DS . Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining. Am J Pathol 1989; 134: 327\u2013336.","journal-title":"Am J Pathol"},{"key":"BF2403387_CR10","first-page":"759","volume":"135","author":"DS Weinberg","year":"1989","unstructured":"Weinberg DS . The role of cell cycle activity in the generation of morphologic heterogeneity in non-Hodgkin's lymphoma. Am J Pathol 1989; 135: 759\u2013770.","journal-title":"Am J Pathol"},{"key":"BF2403387_CR11","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/00000478-199008000-00007","volume":"14","author":"P Lardelli","year":"1990","unstructured":"Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES . Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990; 14: 752\u2013763.","journal-title":"Am J Surg Pathol"},{"key":"BF2403387_CR12","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","volume":"14","author":"GA Velders","year":"1996","unstructured":"Velders GA, Kluin-Nelemans JC, de BC, Hermans J, Noordijk EM, Schuuring E et al. Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol 1996; 14: 1269\u20131274.","journal-title":"J Clin Oncol"},{"key":"BF2403387_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0609.2002.01677.x","volume":"69","author":"R Raty","year":"2002","unstructured":"Raty R, Franssila K, Joensuu H, Teerenhovi L, Elonen E . Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol 2002; 69: 11\u201320.","journal-title":"Eur J Haematol"},{"key":"BF2403387_CR14","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1073\/pnas.73.11.3872","volume":"73","author":"M Gellert","year":"1976","unstructured":"Gellert M, Mizuuchi K, O\u2019Dea MH, Nash HA . DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci USA 1976; 73: 3872\u20133876.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403387_CR15","first-page":"424","volume":"23","author":"U Kellner","year":"2000","unstructured":"Kellner U, Rudolph P, Parwaresch R . Human DNA-topoisomerases \u2013 diagnostic and therapeutic implications for cancer. Onkologie 2000; 23: 424\u2013430.","journal-title":"Onkologie"},{"key":"BF2403387_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(02)00715-5","volume":"3","author":"U Kellner","year":"2002","unstructured":"Kellner U, Sehested M, Jensen PB, Gieseler F, Rudolph P . Culprit and victim \u2013 DNA topoisomerase II. Lancet Oncol 2002; 3: 235\u2013243.","journal-title":"Lancet Oncol"},{"key":"BF2403387_CR17","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1073\/pnas.81.9.2616","volume":"81","author":"S DiNardo","year":"1984","unstructured":"DiNardo S, Voelkel K, Sternglanz R . DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc Natl Acad Sci USA 1984; 81: 2616\u20132620.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403387_CR18","doi-asserted-by":"publisher","first-page":"9531","DOI":"10.1021\/bi00493a006","volume":"29","author":"M Charron","year":"1990","unstructured":"Charron M, Hancock R . DNA topoisomerase II is required for formation of mitotic chromosomes in Chinese hamster ovary cells: studies using the inhibitor 4\u2032-dimethylepipodophyllotoxin 9-(4,6-O-thenylidene-beta-D-glucopyranoside). Biochemistry 1990; 29: 9531\u20139537.","journal-title":"Biochemistry"},{"key":"BF2403387_CR19","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/bjc.1997.227","volume":"75","author":"H Turley","year":"1997","unstructured":"Turley H, Comley M, Houlbrook S, Nozaki N, Kikuchi A, Hickson ID et al. The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. Br J Cancer 1997; 75: 1340\u20131346.","journal-title":"Br J Cancer"},{"key":"BF2403387_CR20","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1073\/pnas.85.19.7177","volume":"85","author":"M Tsai-Pflugfelder","year":"1988","unstructured":"Tsai-Pflugfelder M, Liu LF, Liu AA, Tewey KM, Whang-Peng J, Knutsen T et al. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21\u201322. Proc Natl Acad Sci USA 1988; 85: 7177\u20137181.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403387_CR21","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1016\/S0021-9258(19)37054-1","volume":"267","author":"D Hochhauser","year":"1992","unstructured":"Hochhauser D, Stanway CA, Harris AL, Hickson ID . Cloning and characterization of the 5\u2032-flanking region of the human topoisomerase II alpha gene. J Biol Chem 1992; 267: 18961\u201318965.","journal-title":"J Biol Chem"},{"key":"BF2403387_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/002215549704500210","volume":"45","author":"U Kellner","year":"1997","unstructured":"Kellner U, Heidebrecht HJ, Rudolph P, Biersack H, Buck F, Dakowski T et al. Detection of human topoisomerase II alpha in cell lines and tissues: characterization of five novel monoclonal antibodies. J Histochem Cytochem 1997; 45: 251\u2013263.","journal-title":"J Histochem Cytochem"},{"key":"BF2403387_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<207::AID-PATH223>3.0.CO;2-U","volume":"187","author":"P Rudolph","year":"1999","unstructured":"Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B et al. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications. J Pathol 1999; 187: 207\u2013216.","journal-title":"J Pathol"},{"key":"BF2403387_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/A:1006159016703","volume":"55","author":"P Rudolph","year":"1999","unstructured":"Rudolph P, MacGrogan G, Bonichon F, Frahm SO, de MI, Trojani M et al. Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases. Breast Cancer Res Treat 1999; 55: 61\u201371.","journal-title":"Breast Cancer Res Treat"},{"key":"BF2403387_CR25","first-page":"1406","volume":"9","author":"M Provencio","year":"2003","unstructured":"Provencio M, Corbacho C, Salas C, Millan I, Espana P, Bonilla F et al. The topoisomerase II alpha expression correlates with survival in patients with advanced Hodgkin's lymphoma. Clin Cancer Res 2003; 9: 1406\u20131411.","journal-title":"Clin Cancer Res"},{"key":"BF2403387_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1365-2559.2001.01036.x","volume":"38","author":"P Korkolopoulou","year":"2001","unstructured":"Korkolopoulou P, Angelopoulou M, Siakantari M, Mitropoulos F, Vassilakopoulos T, Zorzos H et al. Evaluation of DNA topoisomerase II alpha expression provides independent prognostic information in non-Hodgkin's lymphomas. Histopathology 2001; 38: 45\u201353.","journal-title":"Histopathology"},{"key":"BF2403387_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/ajcp\/104.1.54","volume":"104","author":"JA Holden","year":"1995","unstructured":"Holden JA, Perkins SL, Snow GW, Kjeldsberg CR . Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas. Am J Clin Pathol 1995; 104: 54\u201359.","journal-title":"Am J Clin Pathol"},{"key":"BF2403387_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/hon.2900020306","volume":"2","author":"G Brittinger","year":"1984","unstructured":"Brittinger G, Bartels H, Common H, Duhmke E, Fulle HH, Gunzer U et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin's lymphomas: results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 1984; 2: 269\u2013306.","journal-title":"Hematol Oncol"},{"key":"BF2403387_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/hon.2900070505","volume":"7","author":"P Meusers","year":"1989","unstructured":"Meusers P, Engelhard M, Bartels H, Binder T, Fulle HH, Gorg K et al. Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol 1989; 7: 365\u2013380.","journal-title":"Hematol Oncol"},{"key":"BF2403387_CR30","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES . Mantle-cell lymphoma. Semin Hematol 1999; 36: 115\u2013127.","journal-title":"Semin Hematol"},{"key":"BF2403387_CR31","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","volume":"87","author":"DD Weisenburger","year":"1996","unstructured":"Weisenburger DD, Armitage JO . Mantle cell lymphoma \u2013 an entity comes of age. Blood 1996; 87: 4483\u20134494.","journal-title":"Blood"},{"key":"BF2403387_CR32","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001."},{"key":"BF2403387_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/oxfordjournals.annonc.a058904","volume":"5","author":"E Zucca","year":"1994","unstructured":"Zucca E, Stein H, Coiffier B . European Lymphoma Task Force (ELTF): report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 1994; 5: 507\u2013511.","journal-title":"Ann Oncol"},{"key":"BF2403387_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","volume":"16","author":"PM Banks","year":"1992","unstructured":"Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data [see comments]. Am J Surg Pathol 1992; 16: 637\u2013640.","journal-title":"Am J Surg Pathol"},{"key":"BF2403387_CR35","first-page":"1689","volume":"142","author":"H Kreipe","year":"1993","unstructured":"Kreipe H, Wacker HH, Heidebrecht HJ, Haas K, Hauberg M, Tiemann M et al. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 1993; 142: 1689\u20131694.","journal-title":"Am J Pathol"},{"key":"BF2403387_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s002920050064","volume":"15","author":"A Bankfalvi","year":"1994","unstructured":"Bankfalvi A, Riehemann K, Ofner D, Checci R, Morgan JM, Piffko J et al. Moist autoclaving. A simplified method for antigen unmasking. Pathologe 1994; 15: 345\u2013349.","journal-title":"Pathologe"},{"key":"BF2403387_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/32.2.6198355","volume":"32","author":"JL Cordell","year":"1984","unstructured":"Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219\u2013229.","journal-title":"J Histochem Cytochem"},{"key":"BF2403387_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/ajcp\/105.6.737","volume":"105","author":"S Kumar","year":"1996","unstructured":"Kumar S, Krenacs L, Otsuki T, Kumar D, Harris CA, Wellmann A et al. bc1-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol 1996; 105: 737\u2013743.","journal-title":"Am J Clin Pathol"},{"key":"BF2403387_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/(SICI)1096-9896(199607)179:3<238::AID-PATH566>3.0.CO;2-W","volume":"179","author":"MM Ott","year":"1996","unstructured":"Ott MM, Helbing A, Ott G, Bartek J, Fischer L, Durr A et al. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 1996; 179: 238\u2013242.","journal-title":"J Pathol"},{"key":"BF2403387_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0046-8177(95)90090-X","volume":"26","author":"SH Swerdlow","year":"1995","unstructured":"Swerdlow SH, Yang WI, Zukerberg LR, Harris NL, Arnold A, Williams ME . Expression of cyclin D1 protein in centrocytic\/mantle cell lymphomas with and without rearrangement of the BCL1\/cyclin D1 gene. Hum Pathol 1995; 26: 999\u20131004.","journal-title":"Hum Pathol"},{"key":"BF2403387_CR41","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/ajcp\/103.6.756","volume":"103","author":"LR Zukerberg","year":"1995","unstructured":"Zukerberg LR, Yang WI, Arnold A, Harris NL . Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 1995; 103: 756\u2013760.","journal-title":"Am J Clin Pathol"},{"key":"BF2403387_CR42","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"LH Argatoff","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD . Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997; 89: 2067\u20132078.","journal-title":"Blood"},{"key":"BF2403387_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","volume":"82","author":"F Bosch","year":"1998","unstructured":"Bosch F, Lopez-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998; 82: 567\u2013575.","journal-title":"Cancer"},{"key":"BF2403387_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/1096-8652(200007)64:3<190::AID-AJH9>3.0.CO;2-B","volume":"64","author":"DD Weisenburger","year":"2000","unstructured":"Weisenburger DD, Vose JM, Greiner TC, Lynch JC, Chan WC, Bierman PJ et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 2000; 64: 190\u2013196.","journal-title":"Am J Hematol"},{"key":"BF2403387_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0959-8049(01)00366-5","volume":"38","author":"NS Andersen","year":"2002","unstructured":"Andersen NS, Jensen MK, de Nully BP, Geisler CH . A Danish population-based analysis of 105 mantle cell lymphoma patients. incidences, clinical features, response, survival and prognostic factors. Eur J Cancer 2002; 38: 401\u2013408.","journal-title":"Eur J Cancer"},{"key":"BF2403387_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","volume":"79","author":"T Hunter","year":"1994","unstructured":"Hunter T, Pines J . Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573\u2013582.","journal-title":"Cell"},{"key":"BF2403387_CR47","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/bjc.1995.529","volume":"72","author":"S Houlbrook","year":"1995","unstructured":"Houlbrook S, Addison CM, Davies SL, Carmichael J, Stratford IJ, Harris AL et al. Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines. Br J Cancer 1995; 72: 1454\u20131461.","journal-title":"Br J Cancer"},{"key":"BF2403387_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/bj3190307","volume":"319","author":"T Asano","year":"1996","unstructured":"Asano T, An T, Mayes J, Zwelling LA, Kleinerman ES . Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene. Biochem J 1996; 319: 307\u2013313.","journal-title":"Biochem J"},{"key":"BF2403387_CR49","first-page":"4213","volume":"51","author":"E Friche","year":"1991","unstructured":"Friche E, Danks MK, Schmidt CA, Beck WT . Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. Cancer Res 1991; 51: 4213\u20134218.","journal-title":"Cancer Res"},{"key":"BF2403387_CR50","first-page":"58","volume":"49","author":"AM Deffie","year":"1989","unstructured":"Deffie AM, Batra JK, Goldenberg GJ . Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. Cancer Res 1989; 49: 58\u201362.","journal-title":"Cancer Res"},{"key":"BF2403387_CR51","doi-asserted-by":"crossref","first-page":"17724","DOI":"10.1016\/S0021-9258(19)77896-X","volume":"263","author":"SM Davies","year":"1988","unstructured":"Davies SM, Robson CN, Davies SL, Hickson ID . Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J Biol Chem 1988; 263: 17724\u201317729.","journal-title":"J Biol Chem"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403387","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T07:46:17Z","timestamp":1705131977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,29]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7,1]]}},"alternative-id":["BF2403387"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403387","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,29]]}}}